Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Breast Cancer | Research article

Time trend of breast cancer mortality in BRAZILIAN men: 10-year data analysis from 2005 to 2015

Authors: Jean Henri Maselli-Schoueri, Fernando Alves Affonso-Kaufman, Claudia Vaz de Melo Sette, Francisco Winter dos Santos Figueiredo, Fernando Adami

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Male Breast Cancer (MBC) is rare, which makes its understanding and treatment be extrapolated from what is known about the occurrence in women, with few epidemiological studies. Therefore, the aim of the present paper was to study breast cancer mortality in adult males in Brazil and its administrative regions between 2005 and 2015.

Methods

Ecological study with data on MBC mortality in adults between 2005 and 2015. Data were obtained from the Mortality Information System of the Department of Informatics of SUS (the Unified Health System of the country). Descriptive statistics were used for MBC mortality and linear regression to analyze the relationship between mortality and the country’s administrative regions. Percentage Change (PC) and Annual Percentage Change (APC) were the trend measures used for MBC mortality for the period.

Results

Between 2005 and 2015, there were 1521 deaths due to MBC in adults in Brazil. Regarding mortality by region, there was great oscillation in the rates of the country as a whole (PC = 113,87; β = 0,009 (IC95% 0,000 – 0,018); r2 = 0,381; P = 0,043). The highest increase in MBC mortality occurred in patients aged 80 years or older (PC = 161,04; β = 0,201 (IC95% 0,640 - 0,339); r2 = 0,550; P = 0,009) and there was significant increase in deaths for the 50–54-year age group (PC = 224,01; β = 0,135 (CI95% 0,052; 0,218); r2 = 0,601; P = 0,005).

Conclusion

Mortality in adults due to MBC increased in Brazil during the study period with the highest percentage increase occurring for individuals aged 80 years or older.
Appendix
Available only for authorised users
Literature
2.
go back to reference Institute of Medicine (US) Committee on Cancer Control in Low- and Middle-Income Countries. In: Sloan FA, Gelband H, editors. Cancer Control Opportunities in Low- and Middle-Income Countries. Washington (DC): National Academies Press (US); 2007. 3, The Cancer Burden in Low- and Middle-Income Countries and How It Is Measured. Available from: https://www.ncbi.nlm.nih.gov/books/NBK54028/. Institute of Medicine (US) Committee on Cancer Control in Low- and Middle-Income Countries. In: Sloan FA, Gelband H, editors. Cancer Control Opportunities in Low- and Middle-Income Countries. Washington (DC): National Academies Press (US); 2007. 3, The Cancer Burden in Low- and Middle-Income Countries and How It Is Measured. Available from: https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK54028/​.
9.
go back to reference Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat. 2004;83:77–86.CrossRef Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat. 2004;83:77–86.CrossRef
13.
go back to reference Coordenação Geral de Informações e Análise Epidemiológica – CGIAE. Consolidação da base de dados de 2011. Juan José Cortez Escalante e Dacio de Lyra Rabello Neto. Brasilia, 28 de maio de 2013. Coordenação Geral de Informações e Análise Epidemiológica – CGIAE. Consolidação da base de dados de 2011. Juan José Cortez Escalante e Dacio de Lyra Rabello Neto. Brasilia, 28 de maio de 2013.
14.
go back to reference Laurenti R, Jorge MHPM, Gotlieb SLD. The accuracy of the official mortality and morbidity statistics related to chronic non-communicable diseases. Ciên Saúde Colet. 2004;9(4):909–20.CrossRef Laurenti R, Jorge MHPM, Gotlieb SLD. The accuracy of the official mortality and morbidity statistics related to chronic non-communicable diseases. Ciên Saúde Colet. 2004;9(4):909–20.CrossRef
16.
go back to reference Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new who standard. In: GPE Discussion Paper Series: No.31 EIP/GPE/EBD World Health Organization; 2001. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new who standard. In: GPE Discussion Paper Series: No.31 EIP/GPE/EBD World Health Organization; 2001.
20.
go back to reference IBGE. Tábua completa de mortalidade para o Brasil – 2015 Breve análise da evolução da mortalidade no Brasil. Brasilia; 2016. IBGE. Tábua completa de mortalidade para o Brasil – 2015 Breve análise da evolução da mortalidade no Brasil. Brasilia; 2016.
23.
go back to reference Boyages J. Male breast cancer: taking control. Australia: John Boyages BC Publishing Sydney; 2015. Boyages J. Male breast cancer: taking control. Australia: John Boyages BC Publishing Sydney; 2015.
25.
go back to reference Kreiter E, Richardson A, Potter J, Yasui Y. Breast cancer: trends in international incidence in men and women. Br J Cancer. 2014;110(7):1891–7.CrossRef Kreiter E, Richardson A, Potter J, Yasui Y. Breast cancer: trends in international incidence in men and women. Br J Cancer. 2014;110(7):1891–7.CrossRef
26.
go back to reference Miao H, Verkooijen HM, Chia K-S, Bouchardy C, Pukkala E, Larønningen S, Mellemkjær L, Czene K, Hartman M. Incidence and Outcome of Male Breast Cancer: An International Population-Based Study. J Clin Oncol. 2011;29(33):4381–6.CrossRef Miao H, Verkooijen HM, Chia K-S, Bouchardy C, Pukkala E, Larønningen S, Mellemkjær L, Czene K, Hartman M. Incidence and Outcome of Male Breast Cancer: An International Population-Based Study. J Clin Oncol. 2011;29(33):4381–6.CrossRef
Metadata
Title
Time trend of breast cancer mortality in BRAZILIAN men: 10-year data analysis from 2005 to 2015
Authors
Jean Henri Maselli-Schoueri
Fernando Alves Affonso-Kaufman
Claudia Vaz de Melo Sette
Francisco Winter dos Santos Figueiredo
Fernando Adami
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-5261-1

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine